[1]
R. Garg, “Observational study to assess efficacy and safety of Bifidobacterium longum W11 + fructo-oligosaccharide combination in patients with irritable bowel syndrome”, Int J Res Med Sci, vol. 14, no. 10, pp. 4412–4420, Sep. 2026.